Caldan Therapeutics is a spin-out company from the Universities of Glasgow and Southern Denmark, specializing in developing novel therapeutics targeting free fatty acid receptors for the treatment of metabolic disease, including Type 2 Diabetes and non-alcoholic steatohepatitis (NASH)
Caldan Therapeutics is a spin-out company from the Universities of Glasgow and Southern Denmark, specializing in developing novel therapeutics targeting free fatty acid receptors for the treatment of metabolic disease, including Type 2 Diabetes and non-alcoholic steatohepatitis (NASH).